Cargando…
Small Cell Lung Carcinoma: Current Diagnosis, Biomarkers, and Treatment Options with Future Perspectives
Small cell lung cancer (SCLC) is an aggressive malignancy characterized by rapid proliferation, early dissemination, acquired therapy resistance, and poor prognosis. Early diagnosis of SCLC is crucial since most patients present with advanced/metastatic disease, limiting the potential for curative t...
Autores principales: | Krpina, Kristina, Vranić, Semir, Tomić, Krešimir, Samaržija, Miroslav, Batičić, Lara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377361/ https://www.ncbi.nlm.nih.gov/pubmed/37509621 http://dx.doi.org/10.3390/biomedicines11071982 |
Ejemplares similares
-
Significance of the Lung Immune Prognostic Index for Assessment of the Reliability of the Clinical Treatment Outcome for Advanced Non-Small-Cell Lung Cancer in Patients with COVID-19 Infection
por: Krpina, Kristina, et al.
Publicado: (2022) -
Comprehensive genomic profiling of a metastatic small cell lung carcinoma with a complete and long-term response to atezolizumab: A case report
por: Tomic, Kresimir, et al.
Publicado: (2023) -
The Challenges and Opportunities of the Implementation of Comprehensive Genomic Profiling in Everyday Clinical Practice with Non-Small Cell Lung Cancer: National Results from Croatia
por: Čerina, Dora, et al.
Publicado: (2023) -
Immunotherapy for thymoma
por: Jakopovic, Marko, et al.
Publicado: (2020) -
Treatment of toxoplasmosis: Current options and future perspectives
por: Konstantinovic, Neda, et al.
Publicado: (2019)